Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)
Oncology Reports · 05.12.2025 · 55 (2) · 1-19
DOI: 10.3892/or.2025.9036 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Reports, online erschienen am 05.12.2025. Verfasst von Wenpu Zhu und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China. Hauptthemen laut MEDLINE: Alternative Splicing, Drug Resistance, Neoplasm, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, Henan 450008, P.R. China.
Zitieren
APA
Zhu, W., Wu, Z., Luv, C., Bao, B., Zhao, W., Chen, G., Yang, H., Ai, H., Liu, F., & Li, Z. (2025). Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review). Oncology Reports, 55(2), 1-19. https://doi.org/10.3892/or.2025.9036
Vancouver
Zhu W, Wu Z, Luv C, Bao B, Zhao W, Chen G, et al. Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review). Oncology Reports. 2025;55(2):1-19. doi:10.3892/or.2025.9036
BibTeX
@article{Zhu2025,
author = {Zhu, Wenpu and Wu, Zikun and Luv, Chai and Bao, Banghe and Zhao, Weijie and Chen, Guanglong and Yang, Hang and Ai, Huihan and Liu, Faqiang and Li, Zhi},
title = {Alternative splicing in cancer drug resistance: Mechanisms and therapeutic prospects (Review)},
journal = {Oncology Reports},
year = {2025},
volume = {55},
number = {2},
pages = {1--19},
doi = {10.3892/or.2025.9036}
}
EUVIMED